Literature DB >> 20144653

Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis.

R Smieskova1, P Fusar-Poli, P Allen, K Bendfeldt, R D Stieglitz, J Drewe, E W Radue, P K McGuire, A Riecher-Rössler, S J Borgwardt.   

Abstract

OBJECTIVES: In early stage psychosis research the identification of neurobiological correlates of vulnerability to schizophrenia is an important hurdle.
METHODS: We systematically reviewed the neuroimaging publications on high-risk subjects with subsequent transition to psychosis (HR-T) and conducted a meta-analysis calculating the effect size Cohen's d.
RESULTS: Out of 30 identified studies 25 met the inclusion criteria. Structural (s)MRI studies showed small to medium effect sizes of decreased prefrontal, cingulate, insular and cerebellar gray matter volume in HR-T compared to high-risk subjects without transition (HR-NT). Meta-analysis revealed relatively larger whole brain volumes in HR-T compared to HR-NT subjects (mean Cohen's d 0.36, 95% CI 0.27-0. 46). Compared to HR-NT, HR-T subjects showed in functional imaging studies reduced brain activation in prefrontal cortex, reduced neuronal density, and increased membrane turnover in frontal and cingulate cortex with medium to large effect sizes.
CONCLUSIONS: Despite methodological differences between studies, structural and neurochemical abnormalities in prefrontal, anterior cingulate, medial temporal and cerebellar cortex might be predictive for development of psychosis within HR subjects.

Entities:  

Mesh:

Year:  2010        PMID: 20144653     DOI: 10.1016/j.neubiorev.2010.01.016

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  115 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.

Authors:  Nikolaos Koutsouleris; Stefan Borgwardt; Eva M Meisenzahl; Ronald Bottlender; Hans-Jürgen Möller; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

3.  Early prodromal symptoms can predict future psychosis in familial high-risk youth.

Authors:  Neeraj Tandon; Debra Montrose; Jai Shah; R P Rajarethinam; Vaibhav A Diwadkar; Matcheri S Keshavan
Journal:  J Psychiatr Res       Date:  2011-11-04       Impact factor: 4.791

4.  Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Authors:  Stefan Borgwardt; Renata Smieskova; Kerstin Bendfeldt; Eva Bühlmann; Gregor Berger; Jacqueline Aston; Ute Gschwandtner; Marlon Pflueger; Rolf-Dieter Stieglitz; Anita Riecher-Rössler; Ernst-Wilhelm Radue
Journal:  J Psychiatry Neurosci       Date:  2010-05       Impact factor: 6.186

5.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

Review 6.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

7.  Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Authors:  Tatsunobu Natsubori; Hideyuki Inoue; Osamu Abe; Yosuke Takano; Norichika Iwashiro; Yuta Aoki; Shinsuke Koike; Noriaki Yahata; Masaki Katsura; Wataru Gonoi; Hiroki Sasaki; Hidemasa Takao; Kiyoto Kasai; Hidenori Yamasue
Journal:  Schizophr Bull       Date:  2013-09-10       Impact factor: 9.306

8.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

9.  Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matthew J Smith; Matcheri S Keshavan
Journal:  J Soc Social Work Res       Date:  2018-04-27

10.  Identifying a treatable psychosis-risk cohort.

Authors:  Jean Addington
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.